Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab

被引：2
|
作者：
Garceau, Patrick [1 ]
Couture, Christian [1 ]
Cantin, Bernard [1 ]
Bernier, Vincent [2 ]
Senechal, Mario [1 ]
机构：
[1] Hop Laval, Inst Cardiol Quebec, Dept Cardiol, Ste Foy, PQ G1V 4G5, Canada
[2] Univ Quebec, Ctr Hosp, Ste Foy, PQ G1V 2M3, Canada
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2008年 / 27卷 / 08期
关键词：
D O I：
10.1016/j.healun.2008.05.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Post-transplant lymphoproliferative disorder (PTLD) is often associated with Epstein-Barr virus (EBV). However, in this report, we describe a heart transplant recipient with pathologically proven EBV-positive PTLD with undetectable virus by polymerase chain reaction. The patient had remission after anti-CD20 antibody treatment early after transplantation.
引用
收藏
页码：928 / 931
页数：4
相关论文
共 50 条
  • [1] Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease
    Savoldo, B
    Rooney, CM
    Quiros- Tejeira, RE
    Caldwell, Y
    Wagner, HJ
    Lee, T
    Finegold, MJ
    Dotti, G
    Heslop, HE
    Goss, JA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) : 566 - 572
  • [2] Epstein-Barr virus-associated post-transplant lymphoproliferative disorder
    Bar-Natan, M
    Nagler, A
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2006, 8 (03): : 205 - 207
  • [3] Genomic diversity of Epstein-Barr Virus in post-transplant lymphoproliferative disorder
    Martinez, Olivia
    Maloney, Eden
    Busque, Vincent
    Hui, Sin Ting
    Esquivel, Carlos O.
    Krams, Sheri
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [4] Epstein-Barr Virus Genome Variation in Post-Transplant Lymphoproliferative Disorder
    Maloney, Eden
    Busque, Vincent A.
    Hui, Sin Ting
    Krams, Sheri M.
    Esquivel, Carlos O.
    Martinez, Olivia M.
    TRANSPLANTATION, 2018, 102 : S95 - S95
  • [5] Genomic Diversity of Epstein-Barr Virus in Post-Transplant Lymphoproliferative Disorder
    Maloney, E.
    Martinez, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 402 - 402
  • [6] Chorioretinal post-transplant lymphoproliferative disorder induced by the Epstein-Barr virus
    Demols, PF
    Cochaux, PM
    Velu, T
    Caspers-Velu, L
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (01) : 93 - 95
  • [7] Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: Three-year experience
    Rogers, BB
    Sommerauer, J
    Quan, A
    Timmons, CF
    Dawson, DB
    Scheuermann, RH
    Krisher, K
    Atkins, C
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 1998, 1 (06) : 480 - 486
  • [8] Epstein-Barr virus and post-transplant lymphoproliferative disease
    Holmes, RD
    Sokol, RJ
    PEDIATRIC TRANSPLANTATION, 2002, 6 (06) : 456 - 464
  • [9] Lymphocyte data in Epstein-Barr-virus induced post-transplant lymphoproliferative disorder treated by rituximab
    Entz-Werle, N
    Cojean, N
    Barats, A
    Eyer, D
    Munzer, M
    Uring-Lambert, B
    Falkenrodt, A
    Babin, A
    Lutz, P
    PEDIATRIC TRANSPLANTATION, 2003, 7 (04) : 277 - 281
  • [10] Epstein-Barr virus-related post-transplant lymphoproliferative disorder in the skin
    Yamada, Kazuya
    Motegi, Sei-ichiro
    Amano, Hiroo
    Ishikawa, Osamu
    JOURNAL OF DERMATOLOGY, 2015, 42 (09): : 936 - 937
12345